Maball 500mg Injection (Rituximab)

Maball 500mg Injection is a prescription-based targeted biological medicine for treating blood cancers like non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as certain autoimmune disorders such as rheumatoid arthritis. This injection contains an active ingredient known as rituximab that belongs to the drug class of monoclonal antibodies. It works by targeting the CD20 antigen protein present on B cells. By binding to CD20, it helps the immune system identify and destroy these abnormal B cells. A Rituximab 500mg injection is commonly given in combination with other anticancer medicines for certain cancers.

The injection is administered intravenously as a slow infusion by a qualified doctor in a hospital or clinical setting. The doctor determines the dosage of the Rituximab 500mg injection according to the type of cancer, treatment regimen, age, and overall health of the patient. It should not be self-administered. Patients are advised not to change the dosage and timings prescribed by the doctors because it can cause severe side effects.

Common side effects include fever, chills, weakness, headache, nausea, diarrhea, infections, and infusion-related reactions. A few patients can undergo severe side effects, including severe infusion reactions, serious infections, hepatitis B reactivation, heart problems, and severe skin or mucosal reactions. Most of the Rituximab 500mg injection side effects can leave when the body adapts to the medicine. However, if any side effects persist, inform your doctor immediately.

Screening for hepatitis B may be required before starting treatment. The medicine may cause fetal harm when used during pregnancy. Women who can become pregnant must use effective contraception during treatment. Patients must list all medicines, supplements, and herbal products that they are taking. The Rituximab 500mg injection must be used under medical oversight or medical supervision only. Attend regular tests and follow-ups to monitor the medicine response and reduce side effects. Before making any adjustments, changing the dose, or stopping the treatment, consult with your doctor to maximize the benefit.

Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, and Pemphigus Vulgaris.

Monoclonal antibody-based Maball 500mg Injection (Rituximab 500mg) has multiple side effects due to its chemical composition. Side effects can vary from mild to severe if symptoms remain for a longer period of time. Immediately consult your doctor about it for timely treatment of the same.

Common Side Effects of Maball 500mg Injection:
● Weakness
● Headache
● Fever
● Rashes
● Abdominal Pain
● Redness at the injection site
● Low White Blood Cell Count
● Prone to Infections

Severe Side Effects of Maball 500mg Injection:
● Anaphylaxis
● Tumor Lysis Syndrome
● Progressive Multifocal Leukoencephalopathy
● Infusion-Related Reactions
● Hepatitis B Reactivation

Maball 500mg Injection (Rituximab) should be administered intravenously as a slow infusion, that is, directly into the veins, by an experienced nurse or doctor. Do not self-administer the injection. Consult your doctor for personalized dosage because dosage is entirely dependent upon the disease type and its stage, as well as the overall health of the patient.

● Kim, H., Csaky, K. G., Chan, C. C., Bungay, P. M., Lutz, R. J., Dedrick, R. L., ... & Robinson, M. R. (2006). The pharmacokinetics of rituximab following an intravitreal injection. Experimental eye research, 82(5), 760-766.

● Van der Kolk, L. E., Grillo‐Lopez, A. J., Baars, J. W., Hack, C. E., & Van Oers, M. H. J. (2001). Complement activation plays a key role in the side‐effects of rituximab treatment. British journal of haematology, 115(4), 807-811.

● Onrust, S. V., Lamb, H. M., & Barman Balfour, J. A. (1999). Rituximab. Drugs, 58(1), 79-88.

● Cohen, M. D., & Keystone, E. (2015). Rituximab for rheumatoid arthritis. Rheumatology and therapy, 2(2), 99-111.